Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anteris Technologies Global (AVR) Free Cash Flow (2024 - 2026)

Anteris Technologies Global (AVR) reported Free Cash Flow of -$28.8 million for Q1 2026, down 32.57% year-over-year from -$42.7 million in Q1 2025, and down 52.28% on a QoQ basis from -$18.9 million in Q4 2025.

Anteris Technologies Global (AVR) has 3 years of Free Cash Flow data on file, last reported at -$28.8 million in Q1 2026.

  • Quarterly Free Cash Flow fell 32.57% year-over-year to -$28.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$86.8 million (down 25.86% YoY) and the FY2025 annual result came in at -$79.8 million, down 25.59% from the prior year.
  • Free Cash Flow slipped to -$28.8 million in Q1 2026 per AVR's latest filing, from -$18.9 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$14.0 million in Q2 2024 and bottomed at -$28.8 million in Q1 2026.
  • The 3-year median for Free Cash Flow is -$18.9 million (2025), against an average of -$19.1 million.
  • Peak annual rise in Free Cash Flow reached 1.74% in 2025, while the deepest fall reached 43.03% in 2025.
  • Tracing AVR's Free Cash Flow over 3 years: stood at -$18.6 million in 2024, then retreated by 1.74% to -$18.9 million in 2025, then sank by 52.28% to -$28.8 million in 2026.
  • Per Business Quant, the three latest AVR Free Cash Flow figures stand at -$28.8 million (Q1 2026), -$18.9 million (Q4 2025), and -$19.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 808.60 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 546.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 520.48 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 63.80 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -273.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 158.70 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 120.26 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 76.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 53.30 Mn
10 Anteris Technologies Global 753.31 Mn 753.28 Mn 380,000.00 -28.82 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -28.82 Mn
Mar 31, 2026 -28.82 Mn
Dec 31, 2025 -18.92 Mn
Dec 31, 2025 -18.92 Mn
Sep 30, 2025 -19.05 Mn
Sep 30, 2025 -19.05 Mn
Jun 30, 2025 -20.05 Mn
Jun 30, 2025 -20.05 Mn
Mar 31, 2025 -21.74 Mn
Mar 31, 2025 -21.74 Mn
Dec 31, 2024 -18.60 Mn
Dec 31, 2024 -18.60 Mn
Sep 30, 2024 -14.64 Mn
Sep 30, 2024 -14.64 Mn
Jun 30, 2024 -14.02 Mn
Jun 30, 2024 -14.02 Mn
Mar 31, 2024 -16.25 Mn
Mar 31, 2024 -16.25 Mn